International Society of Liquid Biopsy shared a recent article by Mohamed Alaa Gouda on X:
“Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) .
Key Highlights:
- ctDNA dynamics can predict treatment response earlier than imaging.
- Proposed LB-RECIST criteria aim to standardize ctDNA-based response assessment.
- A step forward for precision oncology and real-time monitoring.
Title: Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
Authors: Mohamed Alaa Gouda, F. Janku, A. Wahida, L. Buschhorn, A. Schneeweiss, N. Abdel Karim, D. De Miguel Perez, M. Del Re, A. Russo, G. Curigliano, C. Rolfo and V. Subbiah
More posts featuring International Society of Liquid Biopsy.